Sigma Of Australia Buyout By Africa's Aspen Appears In Peril
This article was originally published in PharmAsia News
Executive Summary
Sale of Australian firm Sigma Pharmaceuticals appeared in peril after Aspen Pharmacare, Africa's largest drug maker, reduced its acquisition offer